New Year, Same Leaders: Moderna, Tesla Firm Early On Thanks To Deliveries, Vaccine Hopes

The new year begins with strength in some of the same Tech and Biotech stocks that brought us gains through most of 2020. Volatility is advancing a bit, however, and deserves a close look. The vaccines aren't necessarily a magic bullet if logistical problems continue.